N Harbeck

Neural Network Analysis of Follow-Up Data in Primary Breast Cancer

N Harbeck, R Kates, K Ulm, 2000, The International journal of biological markers.

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

N Harbeck, C Thomssen, A. Schneeweiss, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosi

N Harbeck, W Fett, S Loibl, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

N S El Saghir, L Biganzoli, N Harbeck, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Triple-negative breast cancer--current status and future directions.

N Harbeck, L. Pusztai, N. Harbeck, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro.

N Harbeck, N. Harbeck, W. Pritchard, 1999, Proceedings of the National Academy of Sciences of the United States of America.

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

N Harbeck, W Fett, S Loibl, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.